Imagine a world where a cure for sickle cell disease - the blood disorder that afflicts roughly one in every 365 Black Americans - never leaves the lab, because scientists couldn't raise the funding for further research.This is the future we're sleepwalking into, courtesy of the Inflation Reduction Act's well-intentioned but flawed drug pricing policies. […]
The post The Inflation Reduction Act's drug pricing policies are hurting Black Americans appeared first on The Tennessee Tribune.
